4//SEC Filing
Madison Greg 4
Accession 0001114220-18-000037
CIK 0001114220other
Filed
Mar 21, 8:00 PM ET
Accepted
Mar 22, 5:31 PM ET
Size
10.3 KB
Accession
0001114220-18-000037
Insider Transaction Report
Form 4
Madison Greg
See Remarks
Transactions
- Award
Common Stock
2018-03-20+152,500→ 566,586 total - Award
Stock Options (right to buy)
2018-03-20+305,000→ 305,000 totalExercise: $4.16From: 2019-03-20Exp: 2028-03-20→ Common Stock (305,000 underlying)
Footnotes (3)
- [F1]The 152,500 shares are restricted common stock, with one-third of the 152,500 shares vesting on March 20, 2019 and one-twelfth vesting on each of June 20, 2019, September 20, 2019, December 20, 2019, March 20, 2020, June 20, 2020, September 20, 2020, December 20, 2020 and March 20, 2021.
- [F2]Includes 303,747 shares of restricted stock.
- [F3]The stock options vest according to the following schedule: one-third of the 305,000 options will vest on March 20, 2019 and one-twelfth will vest on each of June 20, 2019, September 20, 2019, December 20, 2019, March 20, 2020, June 20, 2020, September 20, 2020, December 20, 2020 and March 20, 2021.
Issuer
KERYX BIOPHARMACEUTICALS INC
CIK 0001114220
Entity typeother
Related Parties
1- filerCIK 0001564955
Filing Metadata
- Form type
- 4
- Filed
- Mar 21, 8:00 PM ET
- Accepted
- Mar 22, 5:31 PM ET
- Size
- 10.3 KB